The Matrix Metalloproteinase-3 (MMP-3) 5A/6A Promoter Polymorphism Is Not Associated with Ischaemic Heart Disease: Analysis Employing a Family Based Approach. Issue 6 (21st May 2013)

• Record Type: Journal Article
• Authors: McGlinchey, Paul G.; Spence, Mark S.; Patterson, Chris C.; Allen, Adrian R.; Murphy, Gillian; Fogarty, Damian; Evans, Alun; McKeown, Pascal P.
• Is Part Of: Disease markers. Volume 20:Issue 6(2004)
• Page Start: 289
• Page End: 294
• Publication Date: 2013-05-21
• Subjects: gene polymorphism -- ischaemic heart disease -- matrix metalloproteinase-3 -- stromelysin-1; Diagnosis -- Periodicals; Biochemical markers -- Periodicals; Pathology -- Periodicals; 616
• DOI: 10.1155/2004/715745
• Languages: English
• ISSNs: 0278-0240

Abstract

Abstract : Matrix metalloproteinase-3 (MMP-3) has been proposed as an important mediator of the atherosclerotic process. The possible role of the functional -1612 5A/6A polymorphism of the MMP-3 gene in the susceptibility to ischaemic heart disease (IHD) was investigated in a well-defined Irish population using two recently described family based tests of association. One thousand and twelve individuals from 386 families with at least one member prematurely affected with IHD were genotyped. Using the combined transmission disequilibrium test (TDT)/sib-TDT and the pedigree disequilibrium test (PDT), no association between the MMP-3 -1612 5A/6A polymorphism and IHD was found. Our data demonstrate that, in an Irish population, the MMP-3 -1612 5A/6A polymorphism is not associated with IHD.